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Embryonic Estrogen Receptors: Do They Have
a Physiological Function?
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In normal estrogen target tissues, estrogen action is mediated through a specific nuclear transcription factor, the estrogen receptor (ER). The site of
estrogen action in the developing organism is therefore determined by cells that contain ER and other necessary tissue and gene-specific
components for estrogen-mediated transcription. Immunocytochemical methods were used to determine the cellular localization and tissue
distribution of ERs in reproductive tracts of mouse fetuses. Nuclear staining for ER was observed in reproductive tracts at fetal days 13 to 15. ERs
were present in the precursors of both male and female reproductive tracts at these early developmental stages, which may be attributable to their
similar embryonic origins. However, as the tissues undergo sexual differentiation at later fetal and early neonatal ages, ER increases in the female
reproductive tracts as compared with the male. ER was detected by immunoblotting on fetal day 10 (before sexual differentiation) in extracts of
whole mouse embryos. To determine whether ER and progesterone receptor genes are expressed earlier in development, we examined RNA from
preimplantation mouse embryos using reverse transcriptase-polymerase chain reaction techniques. ER mRNA was found in oocytes and fertilized
eggs. Message concentration declined at the 2-cell stage and reached its lowest level at the 5- to 8-cell stage. ER mRNA was not detectable at the
morula stage but reappeared at the blastocyst stage. Progesterone receptor mRNA was not detectable until the blastocyst stage. The embryonic
expression of ER and progesterone receptor genes in the blastocyst suggests a possible functional requirement for estrogen and progesterone
receptors in preimplantation embryos. - Environ Health Perspect 103(Suppl 7):69-72 (1995)
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A combination ofrecent and older observa-
tions has raised intriguing questions about
the role ofestrogenic hormones in the early
embryo. The new data, which are based on
two different approaches, paradoxically
appear to be contradictory. The results of
the first approach are summarized in
Figure 1 (1) and show that early mouse
embryos from the unfertilized state to the
3- to 4-cell stage contain what appears to
be maternal messages for the estrogen
receptor (ER) (1,2). Furthermore, the ER
mRNA reappears at the blastocyst stage,
indicating that the embryonic genome
expresses the gene (Figure 2) (1).
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--- ERmRNA Immunocytochemical studies show that
PRmRNA all the cells ofthe blastocyst appear to have
ER present (3). Additional data indicate
that the progesterone receptor mRNA,
which is usually considered to be responsive
to estrogen, also appears for the first time at
the blastocyst stage. It is still not possible to
Embryonic say conclusively whether these receptors are
message physiologically active, but there are few
examples of nonmutated ER receptors in
target cells that are inactive. These studies
4 5 coupled with older reports in the literature
ion support the notion that ER may have a
novel role in the development ofthe mam-
malian embryo. The presence of ER in all
cells ofthe blastocyst increases the possibil- blastocyst ity ofestrogenic effects that lead to changes
in tissues and in cells that are not ordinarily
considered to be estrogen targets.
In marked contrast to the above obser-
vations, the elegant studies from Korach's
group (4) describe "gene knockout" strate-
Implantation gies to produce a mouse with a defective
ER gene. This defective gene has an insert
that should prevent the production ofnor-
of ER and PR in mal mRNA and limit the production of a
R and PR mRNA normally active ER protein. These mice
nhiptortespage showedgrossly abnormalreproductive tract The correspond- gv
Thedrawing of development aspredicted. It was also noted
Nvelopment was that the males were infertile.
ie origin of the A puzzling aspect of these observations
also indicated. is that the presence of the receptor in the
and Gorski(1). early embryo implies an essential role for
Environmental Health Perspectives
I
69GORSKIAND HOU
the ER in early embryonic development
such as implantation or some other critical
function. Furthermore, the widespread dis-
tribution ofembryonic ER suggests a more
generalized requirement for ER than solely
reproduction. Yet, the ER-deficient mice
appear to develop normally except for their
reproductive organs. In several other cases,
important genes that were "knocked out"
also showed only limited effects on devel-
opment (5-7). It has been suggested that
in such cases the organism has developed
more than one gene to regulate such a criti-
cal mechanism. Whether or not such a sec-
ond mechanism exists for ER-dependent
developmental regulation is not yet clear.
Results from older literature lead us to
ask other questions about the role ofER in
the embryo. It has been known since the
1960s that administration ofhigh doses of
the synthetic estrogen diethylstilbestrol
(DES) to pregnant women caused dramatic
and widespread deleterious effects on the
offspring from those pregnancies (8). The
resulting clear-cell carcinomas ofthe vagina
of adolescent daughters and widespread
abnormalities in sons emphasized the pow-
erful effects of estrogens on this develop-
mental stage and revealed the long time
interval between embryonic exposure and
resulting pathology in the adult. These
observations also point out that the treated
mothers did not develop any of the symp-
toms observed in the fetuses. This suggests
that embryonic exposure to estrogen repre-
sents a new and different environment in
which estrogen and its receptor functions,
as compared with the adult.
More carefully controlled experiments
have been carried out in which DES was
injected into pregnant mice on days 9 to 16
of gestation (9-12). These studies also
resulted in definite developmental abnor-
malities in both male and female offspring
from the DES-treated pregnancies. As in the
human studies, the DES effects were only
seen in the fetal animals exposed to estrogen
and not in the maternal hosts. Thus, the
cells of the midgestational mouse fetus,
which can be assumed to be in an early state
of development, respond differently than
cells from the same tissues of the adult,
which are in alaterstages ofdevelopment.
Another widely used experimental sys-
tem is the estrogen-injected neonatal
mouse or rat (8,13-15). These treated
mice also respond differently to estrogen
than adults do. The estrogen-treated
neonates exhibit a high incidence of
epithelial cancer after they reach sexual
maturity compared to controls.
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Figure 2. Expression of the ER gene. (A) Agarose gel showing the polymerase chain reaction (PCR) product
amplified with primers mERo and mERp. RNA from 1.8 embryos was included in each sample. Uterine RNA (50 pg)
was used as a positive control. The annealing temperature for PCR was 65°C, and 17 plus 33 cycles were run. (B)
Autoradiogram of Southern blot for the gel shown in A. (C) Southern blot analysis of the PCR product amplified
with primers mERa and mERb. RNA from 3.6 embryos was included in each sample. Uterine RNA (100 pg) was
used as a positive control. The annealing temperature for PCR was 62°C, and 20 plus 35 cycles were run. Lane M,
molecular size markers (lengths at left in nucleotides). Reproduced with permission from Hou and Gorski (1).
'Wash controls.
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Thus, from day 9 of gestation to
approximately 5 days after birth (9-25
days postconception), estrogen target cells
respond to estrogen in a manner that leads
to an abnormal or cancerous response from
subsequent exposure to estrogen when the
animals reach sexual maturity. Since differ-
entiation of the reproductive tracts starts
about days 12 to 13 in these species, the
ER is no longer distributed randomly,
which appears to be the case in the very
early embryo at the blastocyst stage (gesta-
tion days 4 to 5). This raises the question
as to whether exposure to estrogen at the
blastocyst stage might lead to an even
broader array of effects in the adult.
Perhaps such effects are limited to cells
that contain ER in the adult, but it is pos-
sible that changes in the cellular environ-
ment induced by embryonic exposure to
estrogen might not be dependent on later
exposure to estrogen.
These observations also recall reports in
the literature about breast cancer in which
early menarche is associated with increased
risk of breast cancer, whereas early preg-
nancy is associated with lower risk ofbreast
cancer (8). In this case it is believed that
the developmental state of the mammary
cells may explain this phenomenon. The
early development ofmammary cells under
the influence of the hormones associated
with pregnancy may result in a cellular
environment that is comparable to the
adult mice or humans in the experiments
described above. Fetal cells, in contrast,
have not yet differentiated and are suscep-
tible to abnormal differentiation in
response to estrogen exposure at these early
stages of development. Early menarche
may principally involve exposure to estro-
gen whereas pregnancy exposes the target
cells to a complex array of hormones that
includes estrogens, progestins, placental
gonadotropins, placental lactogens, and
probably others. Thus, the estrogens and
progestins produce different effects in cells
that are in varying states ofdifferentiation;
at the same time these hormones are caus-
ing changes in the differentiation of these
same target cells.
The development of the reproductive
tracts of both males and females is con-
trolled by sex steroid hormones. In previ-
ous studies from this laboratory, Greco et
al. (16-18) showed that ER is present in
both male and female mice from gesta-
tional day 10 and later, with definite evi-
dence of ER being present in reproductive
tissues at gestational day 1 or later. This
includes the gonads (Figure 3) (18) as well
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Figure 3. Immunocytochemistry for ER on frozen sections from fetal mouse gonads taken on 13, 15, 17, and 19
days postconception. An asterisk (*) indicates that on day 13 gender was not apparent and the fetus could be
either female or male before sexual differentiation. Female: nuclear staining was only observed on day 15, and the
intensity of staining varied between experiments. Male: nuclear staining was observed on days 13 and 15; Leydig
cells stained on fetal day 15. On days 17 and 19, peritubular cells of the testes stained for ER. Bar=50 pm.
Reproduced with permission from Greco et al. (161.
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Figure 4. Immunoblots of extracts prepared from female and male reproductive tracts collected 15, 17, and 19
days after fertilization; 19 days after fertilization is date of birth (DOB). For males, the testes were separated from
the associated ducts of the reproductive tract and prepared separately for the immunoblots. ND, not determined.
Protein concentration (pg) and approximate number of fetuses pooled are listed below the photograph.
Reproduced with permission from Greco et al. (16).
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as the primitive reproductive tracts (Figure
4) (18) of both fetal males and females.
These observations likely explain why both
sexes show abnormalities after exposure to
DES in utero.
None of the above observations pro-
vides an explanation for the apparent con-
tradiction presented by the presence ofER
in the embryo and, with the exception of
the reproductive organs, the apparent nor-
mal development ofthe ER-negative mice.
This paradox may have little relevance to
the problem of cancer induced by embry-
onic exposure to estrogen. If embryonic
ERs are physiologically active, then cellular
responses in the embryonic cells will occur
in a cellular environment that is unique and
different from the cellular environment
normally present in cells from estrogen-
regulated adult tissues. This could be one
step in the multistep sequence that leads to
the transformed state ofcancer cells found
in the adult. The embryo may normally be
well protected from estrogen exposure due
to a variety of mechanisms that limit the
concentration of 17P-estradiol, the estro-
gen that is normally found in most species.
However, such mechanisms may not pro-
tect against estrogens such as DES, which
are not affected by the mechanisms that
limit 17p-estradiol. For example, DES is
not bound by a-feto protein, which
sequesters most of the estradiol in the
blood offetal and neonatal rats. Also, DES
is not metabolized in the same manner as
estradiol and therefore is cleared from the
animal at a much slower rate. That mecha-
nisms may be involved at very early embry-
onic stages, such as the blastocyst, is not
clear but could have great importance in
relation to normal development.
Currently there is a great deal of inter-
est in environmental estrogens that origi-
nate from sources such as chemical
processing or foods that contain mycotox-
ins or phytoestrogens. Whether such estro-
gens have effects on the developing embryo
is not clear at this time, but one critical
component of such a response, the ER,
appears to be present in all cells ofthe early
embryo. Therefore, such a response is a
possibility that must be considered.
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